C57BL/6 (B6) and B6 background STAT6−/− mice pretreated with IL-18 plus IL-2 showed prominent intestinal mastocytosis and rapidly expelled implanted adult worms of the gastrointestinal nematode Strongyloides venezuelensis. In contrast, identically pretreated mast cell–deficient W/Wv mice failed to do so. Thus, activated mucosal mast cells (MMC) are crucial for parasite expulsion. B6 mice infected with S. venezuelensis third-stage larvae (L3) completed parasite expulsion by day 12 after infection, whereas IL-18−/− or IL-18Rα−/− B6 mice exhibited marked impairment in parasite expulsion, suggesting a substantial contribution of IL-18–dependent MMC activation to parasite expulsion. Compared with IL-18−/− or IL-18Rα−/− mice, S. venezuelensis L3–infected STAT6−/− mice have poorly activated MMC and sustained infection; although their IL-18 production is normal. Neutralization of IL-18 and IL-2 further reduces expulsion in infected STAT6−/− mice. These results suggest that collaboration between IL-18–dependent and Th2 cell–dependent mastocytosis is important for prompt parasite expulsion.
Skip Nav Destination
Article navigation
5 September 2005
Article|
August 29 2005
IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity
Yuki Sasaki,
Yuki Sasaki
1Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya, 663-8501, Japan
2Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, 332-0012, Japan
Search for other works by this author on:
Tomohiro Yoshimoto,
Tomohiro Yoshimoto
1Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya, 663-8501, Japan
2Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, 332-0012, Japan
Search for other works by this author on:
Haruhiko Maruyama,
Haruhiko Maruyama
3Department of Medical Zoology, Nagoya City University Medical School, Nagoya, 467-8601, Japan
Search for other works by this author on:
Tatsuya Tegoshi,
Tatsuya Tegoshi
4Department of Medical Zoology, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan
Search for other works by this author on:
Nobuo Ohta,
Nobuo Ohta
3Department of Medical Zoology, Nagoya City University Medical School, Nagoya, 467-8601, Japan
Search for other works by this author on:
Naoki Arizono,
Naoki Arizono
4Department of Medical Zoology, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan
Search for other works by this author on:
Kenji Nakanishi
Kenji Nakanishi
1Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya, 663-8501, Japan
2Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, 332-0012, Japan
Search for other works by this author on:
Yuki Sasaki
1Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya, 663-8501, Japan
2Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, 332-0012, Japan
Tomohiro Yoshimoto
1Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya, 663-8501, Japan
2Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, 332-0012, Japan
Haruhiko Maruyama
3Department of Medical Zoology, Nagoya City University Medical School, Nagoya, 467-8601, Japan
Tatsuya Tegoshi
4Department of Medical Zoology, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan
Nobuo Ohta
3Department of Medical Zoology, Nagoya City University Medical School, Nagoya, 467-8601, Japan
Naoki Arizono
4Department of Medical Zoology, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan
Kenji Nakanishi
1Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya, 663-8501, Japan
2Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, 332-0012, Japan
CORRESPONDENCE Kenji Nakanishi: [email protected]
Abbreviations used: MMC, mucosal mast cell; mMCP-1, mouse mast cell protease-1; L3, third-stage larvae; VCU, villous crypt units.
Received:
October 26 2004
Accepted:
July 06 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 202 (5): 607–616.
Article history
Received:
October 26 2004
Accepted:
July 06 2005
Citation
Yuki Sasaki, Tomohiro Yoshimoto, Haruhiko Maruyama, Tatsuya Tegoshi, Nobuo Ohta, Naoki Arizono, Kenji Nakanishi; IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity . J Exp Med 5 September 2005; 202 (5): 607–616. doi: https://doi.org/10.1084/jem.20042202
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement